InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Yazji Salim, Directeur Médical. Officer active across 1 company, notably Oncternal Therapeutics, Inc.. In total, 7 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €18k. Activity tracked since 3 January 2022. The latest transaction was disclosed on 3 January 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Yazji Salim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
19,742 shares@ US$0.496115.8% of flowCommon StockSEC:0001209191-24-000973:0
16,299 shares@ US$0.369.5% of flowCommon StockSEC:0001209191-23-041314:0
10,000 shares@ US$0.2854.6% of flowCommon StockSEC:0001209191-23-024371:0
Canonical exit: 11 Jul 2023 (T+90)
9,961 shares@ US$1.0216.8% of flowCommon StockSEC:0001209191-23-002029:0
82,500 shares0Common StockSEC:0001209191-22-043734:0
10,000 shares@ US$1.6936.2% of flowCommon StockSEC:0001209191-22-005557:0
Canonical exit: 27 Apr 2022 (T+90)
57,137 shares0Common StockSEC:0001209191-22-001975:0
7 of 7 declarations
About Yazji Salim
Yazji Salim is Directeur Médical. He has filed 7 disclosures in total, and across the sampled recent filings, buy volume totals EUR 17622 with no sales, between 2022-01-05 and 2024-01-05. The most frequent transaction nature is tax withholding, and the filings concern Oncternal Therapeutics, Inc.
